Helen of Troy Limited reported a $899 million net loss mainly due to an $885.86 million write-down of goodwill and intangible assets. Despite this, the company generated $131.9 million in free cash flow, which helped reduce debt by $136 million. The firm is restructuring its supply chain to reduce reliance on China to below 20% by 2027, aiming to restore margins as tariffed inventory is depleted and new sourcing increases to 55%. Trading at a lower EV/EBITDA multiple than peers, Helen of Troy is positioned for margin recovery and potential stock re-rating driven by tariff mitigation and supply chain improvements.
Sanofi has released its Q2 2026 aide-mémoire document on its investor website to assist financial modeling for the upcoming quarterly results. This memo includes details on non-comparable items, currency impacts, and share count. The full Q2 2026 ear...
Abivax, a clinical-stage biotech company, has temporarily suspended trading of its ordinary shares on Euronext Paris starting July 1, 2026, at 9:00 CEST. This suspension is at Abivax's request to facilitate the confirmation of allocations and final t...
The global human fibrinogen concentrate market is projected to grow from approximately $0.95 billion in 2025 to $2.78 billion by 2035, at a compound annual growth rate (CAGR) of 11.3%. This growth is fueled by increasing cases of bleeding disorders, ...
Forward Industries, Inc. announced that as of July 1, 2026, it has 73,846,883 common shares outstanding after repurchasing 13,316,224 shares. The company also has outstanding options to purchase 1,811,666 shares, restricted and performance stock unit...
Disney and Blue Star Families held a special screening of Toy Story 5 at Camp Pendleton for nearly 500 military family members, featuring appearances by characters and giveaways. Disney CEO Josh D’Amaro surprised attendees with Disneyland tickets to ...
